Disorders of Blood Flow

Introduction

Disorders of blood flow encompass a range of pathologies affecting the vascular system, including abnormalities in lipid metabolism, arterial and venous diseases, and structural vessel changes. Understanding these conditions is essential for recognizing risk factors, clinical manifestations, and treatment strategies in Anatomy & Physiology.

Hyperlipidemia & Atherosclerosis

Normal Laboratory Concentrations

Blood lipid levels are measured to assess cardiovascular risk. The following table summarizes optimal and abnormal values for cholesterol and triglycerides:

Lipid Laboratory Measurement

• Fasting State: Lipid panels are ideally measured after 12 hours fasting to clear chylomicrons and IDL from blood.

• Non-fasting State: Only total cholesterol and HDL are accurate; LDL is commonly calculated.

• LDL Calculation:

• VLDL Approximation: VLDL is estimated by .

Causes of Hyperlipidemia

• Primary (Genetic): Familial hypercholesterolemia (Type IIa) due to LDL receptor dysfunction. Heterozygotes have cholesterol 250-500 mg/dL; homozygotes up to 1000 mg/dL with early onset.

• Secondary (Acquired): High fat/carbohydrate diet, medications (beta-blockers, glucocorticoids, antipsychotics, estrogen/progestin), obesity, diabetes mellitus, hypothyroidism, nephrotic syndrome, liver disease.

Clinical Manifestations of Hyperlipidemia

• Pancreatitis: Associated with hypertriglyceridemia.

• Atherosclerosis: Plaque formation in arteries, leading to coronary artery disease, stroke, aneurysms, peripheral arterial disease, and renal disease.

Atherosclerosis Risk Factors

Atherosclerosis is driven by modifiable and non-modifiable risk factors:

Treatment of Hyperlipidemia

• Lifestyle Modifications: Limit saturated fats, increase physical activity.

• Drug Therapy:

  • Statins: Block cholesterol synthesis

  • Bile Acid Resins: Bind cholesterol-containing bile acids in gut

  • Niacin: Blocks VLDL synthesis, lowers LDL

  • Fibrates: Increase TG clearance, lower VLDL/LDL

  • Ezetimibe: Blocks intestinal cholesterol absorption

  • Lomitapide: Blocks VLDL synthesis

  • PCSK9 inhibitors: Block LDL receptor degradation in liver

Arterial Disorders

Peripheral Arterial Disease (PAD)

PAD is a manifestation of atherosclerosis affecting peripheral arteries, most commonly femoral and popliteal arteries.

• Clinical Presentation: Asymptomatic until significant occlusion; intermittent claudication (pain/fatigue with exertion), rest pain, ulcerations, necrosis, gangrene, thinning skin, muscle wasting, weak/absent pulses.

• Diagnosis: Ankle-Brachial Index (ABI) < 0.9 indicates PAD. Sensitivity and specificity >90%.

• Treatment: Lifestyle modification, exercise, risk factor management, antiplatelet agents (aspirin, clopidogrel, dipyridamole, cilostazol).

Aneurysms and Dissections

Aneurysms are localized dilations of blood vessels, most commonly arteries. Dissections involve tearing of the vessel wall.

• Types of Aneurysms:

  • Berry: Saccular, small, often in cerebral arteries

  • Fusiform: Full circumference dilation

  • Saccular: Outpouching of vessel wall

  • Dissection: Hemorrhage between vessel wall layers

• Risk Factors: Atherosclerosis, hypertension, congenital abnormalities, trauma, infection

Aortic Aneurysms

• Thoracic: 10% of aortic aneurysms; symptoms include pain, dyspnea, stridor, brassy cough, hoarseness, neck/back pain, SVC compression.

• Abdominal: 90% below renal arteries; symptoms include pulsating abdominal mass, pain, thrombus formation, distal emboli, vein distension.

• Rupture Risk: <4cm diameter: 2% risk; >5cm diameter: 10% risk. Treatment is surgical repair.

Aortic Dissection

• Location: Most common in ascending aorta, but can occur anywhere.

• Clinical Manifestations: Sudden intense pain (anterior chest for ascending, back for descending), paralysis, syncope, heart failure, limb ischemia.

• Treatment: Lower vessel wall pressure (beta-blockers, nitroprusside), surgical resection with graft.

Venous Disorders

Venous Thromboembolism (VTE)

VTE includes deep vein thrombosis (DVT) and pulmonary embolism (PE), resulting from blood clot formation and migration.

• Pathophysiology: Virchow’s Triad: Stasis (low blood flow), hypercoagulability, vascular trauma.

• Risk Factors: Immobility, trauma, surgery, cancer, inherited clotting disorders (Factor V Leiden, protein C/S deficiency), hormone therapy, obesity, dehydration, venous catheterization.

• Clinical Manifestations: Often asymptomatic; unilateral pain, tenderness, swelling, elevated WBC, positive D-dimer, risk of pulmonary embolism.

Laboratory Assessment

• D-dimer: Degradation product of cross-linked fibrin. ng/mL is considered negative (high sensitivity); ng/mL requires further testing for VTE.

Prevention and Treatment

• Prevention: Risk factor assessment, mobility, compression devices, stockings, prophylactic anticoagulation (heparin, low molecular weight heparin).

• Treatment: Thrombolytic therapy (TPA), anticoagulant therapy (warfarin, heparin, factor Xa inhibitors: apixaban, rivaroxaban, edoxaban, fondaparinux; direct thrombin inhibitors: dabigatran).

Chronic Venous Disease

Chronic venous disease results from increased venous pressure, compromised venous return, and inflammation, most evident in the lower extremities.

• Risk Factors: Age (>50 years), female gender, obesity, sedentary lifestyle, prolonged sitting/standing, smoking, family history, height.

• Pathophysiology: Venous wall stress leads to hypoxia, wall remodeling, thickening, dilation, increased permeability, leukocyte and RBC extravasation, tissue deposition of fibrin/hemosiderin, proinflammatory cytokine release, decreased elastin synthesis.

• Clinical Manifestations: Progressive disease, varicose veins, lower limb edema, discomfort, skin hardening (lipodermatosclerosis), brown pigmentation, stasis dermatitis, venous ulcers (80% of cases).

Varicose Veins

• Definition: Dilated, tortuous superficial veins, most commonly affecting the saphenous and deep veins of the lower extremities.

• Mechanism: Incompetent vein valves and muscle pump failure lead to inadequate blood return and venous reflux.

• Clinical Features: Visible, twisted veins, heaviness, aching, edema, increased risk of chronic venous insufficiency.

Chronic Venous Insufficiency

• Manifestations: Dilated veins, tissue edema, leg pain/discomfort, heaviness, tenderness, intermittent claudication, cutaneous changes (lipodermatosclerosis, brown pigmentation, stasis dermatitis), venous ulcers.